Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Curing acute leukemias in the 1990s.

C A Corey1, S J Corey

  • 1Department of Internal Medicine, St Paul, Ramsey Medical Center, Minneapolis.

Postgraduate Medicine
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition.

Leukemia·2013
Same author

Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling.

Leukemia·2013
Same author

Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155.

Oncogene·2012
Same author

Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells.

British journal of cancer·2009
Same author

Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway.

Oncogene·2006
Same author

Interaction between growth arrest-DNA damage protein 34 and Src kinase Lyn negatively regulates genotoxic apoptosis.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same journal

CV risk: if you aren't testing ACR, you aren't seeing the full picture.

Postgraduate medicine·2026
Same journal

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Postgraduate medicine·2026
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
See all related articles

Advances in chemotherapy and bone marrow transplantation offer hope for curing acute leukemias. These innovations promise more effective, less toxic treatments and improved long-term survival for patients.

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Background:

  • Acute leukemias remain a significant challenge in hematologic oncology.
  • Despite progress, achieving widespread cures for all acute leukemia subtypes is an ongoing goal.

Purpose of the Study:

  • To review current management strategies for acute leukemias.
  • To discuss the implications of recent research advancements.
  • To highlight the potential for curative therapies in the near future.

Main Methods:

  • Review of recent scientific literature on acute leukemia treatment.
  • Analysis of data on chemotherapy efficacy and toxicity.
  • Evaluation of outcomes in bone marrow transplantation.

Main Results:

Related Experiment Videos

  • Development of more specific and less toxic chemotherapy regimens.
  • Bone marrow transplantation has led to long-term survival in numerous cases.
  • Significant progress suggests potential for broad curability of acute leukemias.

Conclusions:

  • Current therapeutic strategies are improving outcomes for acute leukemia patients.
  • Ongoing research and technological advances are paving the way for potential cures.
  • The integration of targeted therapies and transplantation is key to future success.